Peripartum Cardiomyopathy
( Lancet . 2025;406(10518):2483–2493. doi:10.1016/S0140-6736(25)01451-5) Peripartum cardiomyopathy (PPCM) is a serious and potentially fatal form of heart failure that develops toward the end of pregnancy or in the months following delivery in women with no prior history of heart disease. Over the past 2 decades, increased recognition and research have substantially advanced understanding of its causes, diagnosis, and management. The condition is defined by the presence of left ventricular systolic dysfunction, typically an ejection fraction below 45%, after exclusion of alternative explanations such as congenital, valvular, or pre-existing cardiomyopathies. Despite therapeutic progress, PPCM remains associated with significant maternal and neonatal morbidity and mortality, and only about half of affected women experience full recovery of cardiac function within 6 months.
Authors
- Sonel Goland
- MR Johnson
- K Sliwa
- J Bauersachs
- A Damasceno
- H Al Farhan
- D Hilfiker-Kleiner
Publication Details
- Journal
- Obstetric Anesthesia Digest
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1097/01.aoa.0001288924.55214.de
- Primary Topic
- Cardiovascular Issues in Pregnancy
- Type
- article
- Field-Weighted Citation Impact
- 0.00